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Abstract
Metal-imbalance has been reported as a contributor factor for the degeneration of dopami-
nergic neurons in Parkinson Disease (PD). Specifically, iron (Fe)-overload and copper (Cu)
mis-compartmentalization have been reported to be involved in the injury of dopaminergic
neurons in this pathology. The aim of this work was to characterize the mechanisms of
membrane repair by studying lipid acylation and deacylation reactions and their role in oxi-
dative injury in N27 dopaminergic neurons exposed to Fe-overload and Cu-supplementa-
tion. N27 dopaminergic neurons incubated with Fe (1mM) for 24 hs displayed increased
levels of reactive oxygen species (ROS), lipid peroxidation and elevated plasma membrane
permeability. Cu-supplemented neurons (10, 50 μM) showed no evidence of oxidative
stress markers. A different lipid acylation profile was observed in N27 neurons pre-labeled
with [3H] arachidonic acid (AA) or [3H] oleic acid (OA). In Fe-exposed neurons, AA uptake
was increased in triacylglycerols (TAG) whereas its incorporation into the phospholipid (PL)
fraction was diminished. TAG content was 40% higher in Fe-exposed neurons than in con-
trols. This increase was accompanied by the appearance of Nile red positive lipid bodies.
Contrariwise, OA incorporation increased in the PL fractions and showed no changes in
TAG. Lipid acylation profile in Cu-supplemented neurons showed AA accumulation into
phosphatidylserine and no changes in TAG. The inhibition of deacylation/acylation reac-
tions prompted an increase in oxidative stress markers and mitochondrial dysfunction in Fe-
overloaded neurons. These findings provide evidence about the participation of lipid acyla-
tion mechanisms against Fe-induced oxidative injury and postulate that dopaminergic neu-
rons cleverly preserve AA in TAG in response to oxidative stress.
Introduction
Parkinson disease (PD) is a neurodegenerative disorder associated with progressive neurode-
generation, and it is characterized by pathological α-synuclein (α-syn) aggregation, oxidative
PLOSONE | DOI:10.1371/journal.pone.0130726 June 15, 2015 1 / 20
a11111
OPEN ACCESS
Citation: Sánchez Campos S, Rodríguez Diez G,
Oresti GM, Salvador GA (2015) Dopaminergic
Neurons Respond to Iron-Induced Oxidative Stress
by Modulating Lipid Acylation and Deacylation
Cycles. PLoS ONE 10(6): e0130726. doi:10.1371/
journal.pone.0130726
Academic Editor: Muzamil Ahmad, Indian Institute
of Integrative Medicine, INDIA
Received: January 27, 2015
Accepted: May 22, 2015
Published: June 15, 2015
Copyright: © 2015 Sánchez Campos et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by the Agencia
Nacional de Promocion Cientifica y Tecnologica www.
agencia.mincyt.gob.ar/ (PICT-2010-0936,PICT-2013-
0987) to GAS, Consejo Nacional de Investigaciones
Cientificas y Tecnicas www.conicet.gov.ar
(PIP1122009010068) to GAS and the Universidad
Nacional del Sur www.uns.edu.ar (PGI24B179) to
GAS. The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
stress, elevated tissue iron, and mis-compartmentalization of copper. The ethiopathogenesis of
PD is centered in the progressive loss of dopaminergic neurons, however, the mechanism un-
derlying this process is still poorly understood [1–4].
The central role of iron (Fe) in PD pathology is supported by reports showing that the ad-
ministration of Fe chelators and the overexpression of iron-binding proteins are neuroprotec-
tive in PD animal models [5–7]. Higher levels of divalent metal transporter DMT1 and loss of
DMT1 down regulation in response to increased levels of Fe have been observed in post-mor-
tem brains from PD patients [8].
Even though Fe-overload is a well known event in PD, a complete characterization of the
state of Cu metabolism is still missing. In this respect, an important number of reports de-
scribed the decrease of this metal ion in the substancia nigra neurons of PD patients [9,10].
Lack of appropriate Cu concentrations could lead to disturbances in CuZn superoxide
dismutase (SOD 1) expression and, in consequence, to an increased susceptibility to α-syn
oligomerization and the generation of oxidative stress [9]. Therefore, during PD, Fe-overload
and Cu deficiency provokes a surrounding environment with high levels of oxidative stress for
dopaminergic neurons.
One decisive event for the survival of neuronal cells under oxidative stress injury is the
maintenance of cellular membrane properties. The preservation of physicochemical membrane
properties (fluidity and permeability) during oxidative stress events strongly depends on phos-
pholipid (PL) remodeling and it is therefore related to cellular mechanisms for the regulation
of fatty acids (FA) availability and storage.
Phospholipids are important structural and functional components of biological mem-
branes, which behave as reservoirs of important lipid mediators. The acyl groups of PL are
highly diverse, depending on the polar head group, and are distributed in an asymmetric man-
ner [11,12]. Rapid turnover of the sn-2 acyl moiety of phospholipids is attributed to the con-
certed and coordinated actions of phospholipases A2s (PLA2s) and lysophospholipid
acyltransferases (LPATs). Another important storage of polyunsaturated fatty acids (PUFA),
such as arachidonic acid (AA) and docosahexaenoic acid (DHA), are triacylglycerols (TAG).
TAG remodeling and their fatty acid composition are also crucial for the maintenance of cellu-
lar PUFA levels, a process catalyzed by diacylglycerol acyltransferases (DGAT). Storage of
TAG occurs in lipid droplets (LD) that are considered dynamic organelles regulated in re-
sponse to the metabolic cellular state [13–15].
A link between α-syn, lipid metabolism, fatty acid oxidation, and mitochondrial damage
has been established in PD. It has been proposed that α-syn can interact with FA, oxidized lip-
ids, and LD [16–18]. However, little is known about the mechanisms of FA turnover and lipid
remodeling that operate during oxidative stress injury in dopaminergic neurons.
In view of the above, the purpose of the present work was to determine the role of lipid acyl-
ation mechanisms during Fe-induced injury in dopaminergic neurons and to study the effect
of Cu supplementation during Fe-overload. To this end, N27 dopaminergic cells were incubat-
ed under Fe-overload and Cu-supplementation conditions and the state of lipid acylation/dea-
cylation processes and their role in the neuronal response to oxidative injury were studied.
Materials and Methods
Materials
[3H] oleic acid (OA) and [3H] arachidonic acid (AA) were obtained from New England Nucle-
ar-Dupont (Boston, MA, USA). Triton X-100, 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetra-
zolium bromide (MTT) and thiobarbituric acid (TBA) were obtained from Sigma-Aldrich
(St. Louis, MO, USA). DCDCDHF was obtained from Molecular Probes (Eugene, Oreg., USA).
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Ferrous sulfate (J.T.Baker, cat.# 2070–01) was purchased from EMDMillipore (Millipore, Bed-
ford, MA). Cupric sulfate (Mallinckrodt Chemicals) was purchased from Cientifica Nacional
(Cientifica Nacional, Argentina).
All the other chemicals used in the present study were of the highest purity available. Anti-
bodies: Goat polyclonal anti-LPAAT-θ(T-17) [sc 66789], rabbit polyclonal anti-DGAT1 (H-
255) [sc 32861], mouse monoclonal anti-fatty acid synthase (FAS) (G-11) [sc48357], goat poly-
clonal anti-actin (C-11) [sc 1615], polyclonal horseradish peroxidase (HRP)-conjugated goat
anti-rabbit IgG, polyclonal HRP-conjugated goat anti-mouse IgG and polyclonal HRP-conju-
gated bovine anti-goat IgG were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). Acylation inhibitor (CI-976) and PLA2 inhibitors [arachidonoyl trifluoromethyl ke-
tone (ATK), bromoenol lactone (BEL) and YM 26734] were purchased from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA, USA). Polyvinylidene difluoride membranes were obtained
fromMillipore (Bedford, MA). Nile Red and Hoechst were fromMolecular Probes. LDH-P
UV AA kit was kindly provided by Wiener lab Group. TG color GPO/PAP AA and Colestat
enzimático were purchased fromWiener lab Group.
Cell culture
N27 cells, a rat mesencephalic dopaminergic cell line, were kindly donated by Dr. Patricia
Oteiza (Department of Nutrition, UC DAVIS). Cells were grown and treated in RPMI 1640 me-
dium supplemented with 10% (v/v) fetal bovine serum (FBS, Natocor, Argentina), 100 U/mL
penicillin, 100 μg/mL streptomycin and 0.25 μg/mL amphotericin B at 37°C under 5% CO2.
Experimental treatments
In all the experiments carried out, cells were plated in 35 x 10 mm Cell Culture Dishes and
grown to 80%-90% confluence. Fe2+ and Cu2+ treatments were carried out in serum-free medi-
um. Treatments with inhibitors were performed as follows: medium was removed and replaced
by serum-free media. Inhibitors were subsequently added to the desired final concentration
-10 μM BEL, 50 μMATK, 10 μMYm 26734 and 7,5 μMCI-976-; controls received vehicle
alone (DMSO 0.05%). After 30 min, 1 mM Fe2+, 10 or 50 μMCu2+, their combination or its ve-
hicle (ultrapure water) were added and cells were incubated under these conditions for 24 h un-
less otherwise specified.
Assessment of cell viability
Cell viability was assessed by MTT reduction assay. MTT is a water-soluble tetrazolium salt
that is reduced by metabolically viable cells to a colored, water insoluble formazan salt. After
treatments, MTT (5mg/ml) was added to the cell culture medium at a final concentration of
0.5 mg/ml. After incubating the plates for 2 h at 37°C in a 5% CO2 atmosphere, the assay was
stopped and the MTT-containing medium was replaced with solubilization buffer (20% SDS,
pH 4.7). The extent of MTT reduction was measured spectrophotometrically at 570 nm [19].
Results are expressed as a percentage of the control.
Determination of lipid peroxidation
Lipid peroxidation was determined by the thiobarbituric acid reactive substances (TBARS)
assay, which involves derivatization of malondialdehyde with thiobarbituric acid to produce a
pink product that is quantified in a UV-VIS spectrophotometer. Briefly, after treatments, cells
were scraped off into 300 μl of ice-cold water and mixed with 0.5 ml of 30% trichloroacetic
acid. Then, 50 μl of 5 N HCl and 0.5 ml of 0.75% thiobarbituric acid were added. Tubes were
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capped, the mixtures were heated at 100°C for 30 min in a boiling water bath and the samples
were centrifuged at 1000 x g for 10 min. TBARS were measured spectrophotometrically in the
supernatant at 532 nm [20]. Results are expressed as a percentage of the control.
Determination of cell oxidant levels
Cell oxidative stress was evaluated using the probe 5 (or 6)-carboxy-2’7’-dichlorodihydrofluor-
escein diacetate (DCDCDHF). This probe can cross the membrane and after oxidation, it is
converted into a fluorescent compound. After the corresponding treatments, the medium was
discarded, and RPMI medium containing 10 μMDCDCDHF was added. After 30 min of incu-
bation at 37°C, the medium was removed, cells were rinsed three times with phosphate buffer
saline (PBS) and they were subsequently either imaged with an epifluorescence microscope or
lysed in a buffer containing PBS and 1% NP-40. Fluorescence in the lysates (λex = 495,
λem = 530) was measured in a SLMmodel 4800 fluorimeter (SLM Instruments, Urbana, IL)
[21]. Results are expressed as a percentage of the control.
Measurement of LDH leakage
Lactate Dehydrogenase (LDH) leakage was determined as previously described [22] with slight
modifications. After treatments, incubation medium was centrifuged at 1000 x g for 10 min at
4°C. The resulting supernatant was used to determine LDH activity, which was measured
spectrophotometrically using LDH-P UV AA kit (Wiener lab.), following the manufacturer’s
instructions. Briefly, the conversion rate of reduced nicotinamide adenine dinucleotide to oxi-
dized nicotinamide adenine dinucleotide was followed at 340 nm. Results are expressed as per-
centage of the control.
Evaluation of Mitochondrial Membrane Potential
To assess preservation of mitochondrial membrane potential, cultures were incubated for 20
min before fixation with the fluorescent probe MitoTracker Red (0.1 μg/mL), which labels mi-
tochondria retaining their membrane potential with a bright red fluorescence.
Western blot analysis
For the preparation of total cell extracts, cells (10 × 106 cells) were rinsed with PBS, scraped
and centrifuged. The pellet was rinsed with PBS and resuspended in 80 μl of a buffer containing
50 mM Tris, pH 7.5, 150 mMNaCl, 0.1% Triton X-100, 1% NP-40, 2 mM EDTA, 2 mM
EGTA, 50 mMNaF, 2 mM β-glycerophosphate, 1 mM Na3VO4, 10 μg/ml leupeptin, 5 μg/ml
aprotinin, 1 μg/ml pepstatin, 0.5 mM PMSF, and 0.5 mMDTT. Samples were exposed to one
cycle of freezing and thawing, incubated at 4°C for 60 min and centrifuged at 10000 x g for 20
min. The supernatant was decanted and the protein concentration was measured. Cell lysates
containing 25–50 μg of protein were separated by reducing 7–12.5% polyacrylamide gel elec-
trophoresis and electroblotted to polyvinylidene difluoride membranes. Molecular weight
standards (Spectra Multicolor Broad Range Protein Ladder, Thermo Scientific) were run si-
multaneously. Membranes were blocked with 5% nonfat dry milk in TBS-T buffer (20 mM
Tris-HCl [pH 7.4], 100 mMNaCl, and 0.1% [wt/vol] Tween 20) for 1 h at room temperature
and subsequently incubated with primary antibodies (anti-LPAAT-θ(T-17): sc-66789; DGAT1
(H-255): sc-32861 and Fatty Acid Synthase (G-11): sc-48357), washed three times with TBS-T
and then exposed to the appropriate HRP-conjugated secondary antibody for 1 h at room tem-
perature. Membranes were again washed three times with TBS-T and immunoreactive bands
were detected by enhanced chemiluminescence (ECL; GE Healthcare Bio-Sciences, Buenos
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Aires, Argentina) using standard X-ray film (Kodak X-OMAT AR; GE Healthcare Bio-Sci-
ences). Immunoreactive bands were quantified using image analysis software (Image J, a freely
available application in the public domain for image analysis and processing, developed and
maintained by Wayne Rasband at the Research Services Branch, National Institute of Mental
Health).
Lipid phosphorus measurement
Lipid phosphorus (lipid P) was determined in total lipid extracts using the chemicals and reac-
tions described by Rouser and collaborators[23].
[3H] Arachidonic acid (AA) and [3H] oleic acid (OA) incorporation into
lipids
To evaluate the consequences of incubation with iron and copper on the label distribution
among dopaminergic neuron lipid classes, cells were pre-labeled with [3H] arachidonic acid
(AA, 20:4) or [3H] oleic acid (OA, 18:1). The labeled fatty acid (0.5 μCi per well) was mixed
with unlabeled AA (1.5 μM) in the presence of lipid-free BSA (4 mol AA/mol BSA). Cells were
pre-incubated for 5 h at 37°C with [3H] AA or [3H] OA supplemented medium to allow the la-
beled fatty acid incorporation. After this incubation, the medium was removed and replaced
with serum free medium and cells were treated with 1 mM Fe2+, 50 μMCu2+, the combination
of these metals or the vehicle for 24 h.
After treatments, cells were washed 3 times with PBS, scraped off and subjected to lipid ex-
traction following the method of Bligh and Dyer [24]. Lipid extracts were washed 2 times with
Bligh and Dyer upper phase, dried under N2, resuspended in chloroform/methanol (2:1, vol/
vol) and spotted on silica gel plates. For the resolution of neutral lipids, silica gel G plates were
used and the mobile phase consisted in hexane: eter: acetic acid (50: 50: 2.6). In order to resolve
polar lipids, lipid extracts were spotted on silica gel H plates and phospholipids were separated
by two dimensional thin layer chromatography exactly as described before [23]. Lipid spots
were visualized by exposing the plates to iodine vapors. The regions corresponding to monoa-
cylglycerols (MAG), diacylglycerols (DAG), free fatty acids (FFA) and triacylglycerols (TAG)
were scraped off the silica gel G plates. The regions corresponding to phosphatidylcholine
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phospatidylinositol (PI) and
phosphatidic acid (PA) were scraped off the silica gel H plates. All spots were transferred to
vials where silica was deactivated by the addition of water. Five milliliters of 0.4% (wt/vol)
Omnifluor in toluene/Arkopal N-100 (4:1, vol/vol) were subsequently added. Radioactivity in
lipid spots from the blanks (typically less than 100 dpm) was subtracted from those of
experimental samples.
Lipid droplets staining
After treatments, cells were washed 3 times with M1 buffer (150 mMNaCl, 1 mM CaCl2, 1
mMMgCl2, and 5 mM KCl in 20 mMHEPES buffer, pH 7.4) and stained for 15 min with Nile
Red (Molecular Probes), 1.5 μg/ml in M1 buffer. After rinsing three times with M1 buffer, cells
were observed with a Nikon Eclipse E-600 microscope (Nikon, Melville, NY, USA), using a
K2E Apogee CCD camera driven by CCDOPS software (Santa Barbara Instrument Group,
Santa Barbara, CA, USA) to visualize LD.
Oxidative Injury and Lipid Acylation in Dopaminergic Neurons
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Determination of Plin-2mRNA levels
Total RNA was isolated from dopaminergic neurons after the corresponding treatments using
TRIZOL Reagent (Invitrogen) according to the manufacturer's protocol. RNA was resus-
pended in nuclease-free water and its concentration was assessed from A260:A280 absorbance
ratio in a PicoDrop Spectrophotometer. Samples were stored at −80°C until use. Aliquots con-
taining 2 μg total RNA were used to synthesize cDNA in reactions containing 1 μg Random
Primer hexamers (Biodynamics), 1X M-MLV Reverse Transcriptase Reaction Buffer, 0.5 mM
of each dNTP, 25 UI RNase inhibitor (Promega) and 200 UI M-MLV Reverse Transcriptase
(Promega). Reactants were taken to a final volume of 25 μl with RNase-free water.
The cDNA resulting from RT was amplified by real-time quantitative PCR (qPCR). Gene
expression levels were determined using Rotor-Gene 6000 (Corbett Research, Australia). RT-
qPCR was performed in a final volume of 10 μl using Mezcla Real for Real-Time PCR (Biody-
namics) and 0.2 μM of each primer. Gene-specific primers sequences designed for RT-qPCR
were to Plin-2, forward: gtgacctcagtggctgtgac and reverse: tattggcgaccgcaatct and to Tbp, for-
ward: tgggattgtaccacagctcca and reverse: ctcatgatgactgcagcaaacc and both primer pairs were
purchased from Life Technologies. PCR conditions were as follows: 40 cycles of denaturation
at 94°C for 20 s, annealing and extension at 58°C for 20 s and a final extension step at 72°C for
30 s. Ct values of Plin-2mRNA obtained from 3 different experiments were normalized accord-
ing to the 2-ΔΔCt method, using TATAA-box binding protein (Tbp) as a reference gene. At the
end of the amplification phase, a melting curve analysis was carried out on the product formed
and agarose gel electrophoresis was carried out to confirm product size. The relative level of
Plin-2 is expressed as the relative change in gene expression.
Triacylglycerol and cholesterol measurement
After separation by TLC, the spots corresponding to TAG and cholesterol were scrapped off
the silica and eluted. Total TAG and cholesterol content was measured in aliquots of the lipid
extracts corresponding to 10 μg lipid P, using commercial kits (TG color GPO/PAP AA and
Colestat enzimático) fromWiener laboratory. Aliquots were dried under N2 gas and resus-
pended in 100 μl of isopropyl alcohol and the manufacturer’s instructions were
subsequently followed.
Statistical analysis
Data represent the mean value ± SD of at least three independent experiments, each experi-
ment was performed in triplicate. Statistical significance was determined by either Student’s t-
test or two-way ANOVA followed by a Tukey’s test. p-values lower than 0.05 were considered
statistically significant. For cytochemical studies, 10 fields per sample were analyzed in each
case. The Western Blots shown are a representative image of samples from three
independent experiments.
Results
Effect of Fe2+ overload and Cu2+ supplementation on dopaminergic
neurons
Our laboratory has previously characterized the effects of Fe-induced oxidative stress on cere-
bral cortex synaptic endings, retina and hippocampal neurons [21,22,25]. We have also de-
scribed the activation of several signaling pathways related to lipid messengers during metal
induced oxidative injury in the above-mentioned experimental models [19–21,26,27]. In the
present work, we have characterized the role of PL and TAG acylation and remodeling during
Oxidative Injury and Lipid Acylation in Dopaminergic Neurons
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metal-induced toxicity in dopaminergic neurons. To this end, rat mesencephalic dopaminergic
neurons, N27 cells, were exposed to Cu2+ (10, 50 μM), Fe2+ overload (1 mM) and the combina-
tion of both metals for 24 h. Control conditions were also assessed, replacing metals by an
equal volume of vehicle (ultrapure water). To determine the extent of metal-induced effects on
dopaminergic neurons, cell morphology, generation of reactive oxygen species (ROS), cell via-
bility and lipid peroxidation levels were analyzed. Exposure to Cu2+ ions (10 and 50 μM) did
not significantly alter cell morphology. However, Fe2+ (1 mM) caused typical morphological al-
terations of oxidant cellular injury, such as cytoplasmic retraction, cell body rounding and de-
crease in the number of cells and neuronal projections. These changes in cellular morphology
were not affected when cells were incubated with the combinations Fe-Cu assayed (Fig 1A).
A highly significant increase (300% higher than the controls) in cellular ROS (measured by
using the probe DCDCDHF) was observed after the treatment with 1mM Fe2+ or with Fe-Cu
combinations (1 mM-10 μM; 1 mM-50 μM). However, the presence of Cu2+ alone did not
Fig 1. Effect of Fe2+ overload and Cu2+ supplementation on dopaminergic neurons. (A)
Photomicrographs of cells after the exposure to Cu2+ (10, 50 μM), Fe2+ overload (1 mM), the combination of
both metals or its vehicle for 24 h. Representative images from three different experiments are shown. (B)
Determination of cellular oxidant levels (ROS). Cells were treated as described in A and subsequently
incubated in the presence of 10 μMDCDCDHF. ROS generation by Fe2+ overload (1 mM) was also
evaluated as a time function (0–24h). Cellular oxidant levels were imaged with an epifluorescence
microscope and quantified by spectrofluorimetry. Results are expressed as a percentage of the control and
represent mean ± SD (n = 3)
doi:10.1371/journal.pone.0130726.g001
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increase ROS generation (Fig 1B). Neurons incubated in the presence of iron showed a sus-
tained increase in ROS levels ranging from 1 to 24 h of incubation. Lipid peroxidation levels,
which were analyzed by TBARS assay, were significantly increased by the presence of Fe
(1mM) and with the co-incubation of both metals (approximately 100%, higher than the con-
trol; Fig 2A). Co-incubation with Cu and Fe showed no increase of TBARS levels with respect
to the Fe condition. As shown in Fig 2B, experimental conditions with increased TBARS for-
mation showed an augmentation of cell membrane permeability measured by LDH leakage.
Mitochondrial membrane potential (ΔCm) was also measured in the above mentioned experi-
mental conditions, using the probe Mitotracker CMX-ROS (Fig 2C). In the presence of iron,
ΔCm/ROS ratio strongly decreased, thus demonstrating mitochondrial depolarization. This
fact agree with a decreased mitochondrial function, measured as MTT reduction (Fig 2C).
TBARS and ROS generation were not increased in the presence of lower Fe2+ concentrations
than 1 mM (data not shown). The fact that Fe2+ concentrations ranging from 10 to 200 μM
produced no neuronal damage and that earlier times of incubation (1–6h) with 1 mM Fe2+ did
not produce neuronal damage were the reasons why we exposed dopaminergic neurons to 1
Fig 2. Effect of Fe2+ overload and Cu2+ supplementation on dopaminergic neurons. (A) TBARS assay.
Cells were treated as described in A and lipid peroxidation was studied according to “Materials and Methods”.
Results are expressed as a percentage of the control and represent mean ± SD (n = 8). (B) LDH leakage
assay was assessed in cells after their exposure to the same conditions described in A. Results are
expressed as a percentage of the control and represent mean ± SD (n = 10). (C) Mitochondrial
characterization. Mitochondrial membrane potential (Δᴪ) was measured using the probe Mitotracker Red
CMX-ROS and mitochondrial function was evaluated by MTT reduction assay. Cells were treated as
described in A, mitochondria stained with Mitotracker were visualized by confocal microscopy and MTT
reduction was assessed as specified in “Materials and Methods”. Δψ/ROS ratio was calculated for all the
experimental conditions. Results are expressed as a percentage of the control and represent mean ± SD
(n = 10). Values with different letters (a, b, c, d) are significantly different (p<0.05), one-way ANOVA and
Tukey’s post hoc test.
doi:10.1371/journal.pone.0130726.g002
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mM Fe2+ for 24 hs. In line with this, similar concentrations were used by the study of α-syn
toxicity in a cell model of PD [28].
Cell viability, assessed by MTT reduction assay, was diminished at 50 μMCu, 1 mM Fe and
the combinations of both metals assayed (Fig 2C).
Phospholipid and triacylglycerol acylation in pre-labeled dopaminergic
neurons exposed to metal-induced injury
Pre-labeled dopaminergic neurons with [3H] oleic acid (OA, 18:1) or [3H] arachidonic acid
(AA, 20:4) showed a distinctive profile of FA incorporation into PL and TAG. During Fe-in-
duced injury, OA incorporation was increased in PS, PI and PE (Fig 3A). OA incorporation
into TAG from Fe-exposed neurons showed no changes with respect to control conditions.
whereas its incorporation into MAG and DAG decreased significantly (Fig 3B).
Fig 3. Effects of Fe2+ overload and Cu2+ supplementation on the distribution (%) of [3H] oleic acid (OA)
among dopaminergic neuron lipids. [3H] oleic acid (OA, 18:1) incorporation into (A) Phospholipids (PS, PI,
PC, PE and PA) and (B) Neutral lipids (MAG, DAG, FFA and TAG) were analyzed after cells were pre-labeled
with [3H] (OA) for 5 h at 37°C and subsequently treated with 50 μMCu2+, 1 mM Fe2+, the combination of these
metals or the vehicle for 24 h as described in “Materials and Methods”. Results are expressed as a
percentage of the control of each lipid and represent mean ± SD (n = 3). *p < 0.05 for each condition with
respect to the control; one-way ANOVA and Tukey’s post hoc test.
doi:10.1371/journal.pone.0130726.g003
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Iron-exposed neurons showed decreased levels of AA uptake into PS with respect to control
(Fig 4A). In contrast, AA incorporation into TAG was increased whereas decreased free AA
levels were observed under the same experimental conditions (Fig 4B). Cu-incubations did not
affect OA incorporation but decreased AA incorporation into TAG (Figs 3B and 4B). However,
Cu-incubated neurons showed decreased OA incorporation into PE and increased AA uptake
into PS (Figs 3A and 4A).
TAG levels in dopaminergic neurons exposed to metal-induced injury
The increase observed in TAG-containing AA in Fe-exposed neurons was accompanied by an
increase in mRNA levels of the LD protein Perilipin-2 (PLIN-2), determined by RT-qPCR (Fig
5A). In the presence of Fe, Nile red positive cytoplasmic bodies, were also observed (Fig 5B).
This was coincident with increased TAG levels being 40% higher in Fe-exposed neurons with
respect to controls (Fig 5C). Cu did not produce any increase neither in LD appearance nor in
TAG levels. Cholesterol levels were not changed in any of the experimental conditions tested
Fig 4. Effects of Fe2+ overload and Cu2+ supplementation on the distribution (%) of [3H] arachidonic
acid (AA) among dopaminergic neuron lipids. [3H] arachidonic acid (AA, 20:4) incorporation in (A)
Phospholipids (PS, PI, PC, PE and PA) and (B) Neutral lipids (MAG, DAG, FFA and TAG) was analyzed after
cells were prelabeled with [3H] AA for 5 h at 37°C and treated with 50 μMCu2+, 1 mM Fe2+, the combination of
these metals or the vehicle for 24 hours as described in “Materials and Methods”. Results are expressed as a
percentage of the control of each lipid and represent mean ± SD (n = 3). *p < 0.05 for each condition with
respect to the control; one-way ANOVA and Tukey’s post hoc test.
doi:10.1371/journal.pone.0130726.g004
Oxidative Injury and Lipid Acylation in Dopaminergic Neurons
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(Fig 5D). For further characterizing the mechanisms involved in AA accumulation in TAG
during Fe-induced injury, the expression of DGAT 1, lysophosphatidic acid acyltransferase θ
(LPAAT θ) and fatty acid synthase (FAS) proteins were analyzed byWestern Blot. Intriguingly,
DGAT 1 levels were found to undergo no changes in Fe-exposed neurons whereas Cu-exposed
neurons were observed to decrease the levels of this enzyme (Fig 6A). FAS protein levels were
diminished in Fe-exposed neurons and augmented in Cu-exposed neurons, with respect to
controls and LPAAT-θ levels underwent no changes in any of the experimental conditions ana-
lyzed (Fig 6B and 6C).
Role of lipid acylation/deacylation mechanisms in dopaminergic neurons
exposed to metal-induced injury
Based on the results obtained in lipid acylation process during metal-overload, and in order to
further investigate the far-reaching implication of lipid remodeling during metal-induced
Fig 5. Effect of metal-induced injury on TAG content and formation of LD. (A) RT-qPCR analysis for
Plin-2 transcripts in N27 cells after incubation for 5 h with 1 mM Fe2+, 50 μMCu2+, the combination of these
metals or the vehicle. Data was normalized to Tbp as internal reference gen using the 2-ΔΔCt method (n = 3).
(B) Fluorescence images of dopaminergic neurons exposed to 1 mM Fe2+, or the vehicle for 24 hours,
stained with Nile Red to detect LD. Representative images from three different experiments are shown. (C)
TAG content in N27 incubated in the presence of 1 mM Fe2+, 50 μMCu2+, the combination of these metals or
the vehicle for 24 hours. Results are expressed as a percentage of the control and represent mean ± SD
(n = 3). (D) Cholesterol content in N27 incubated in the presence of 1 mM Fe2+, 50 μMCu2+, the combination
of these metals or the vehicle for 24 hours. Results are expressed as a percentage of the control and
represent mean ± SD (n = 3). *p < 0.05 for each condition with respect to the control; one-way ANOVA and
Tukey’s post hoc test.
doi:10.1371/journal.pone.0130726.g005
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Fig 6. Western blot analyses of the enzymes involved in lipid accumulation. Cells were exposed to Cu2+
(10, 50 μM), Fe2+ overload (1 mM), the combination of both metals or its vehicle for 24 h. Cell lysates were
prepared for Western blot as described in “Material and Methods” and (A) DGAT 1 expression levels, (B) FAS
expression levels and (C) LPAAT-θ expression levels were assessed. Western blot in each case is
representative of three different experiments. Bands of proteins were quantified using scanning densitometry.
Data in the graphs above each blot represent the ratio between cellular protein expression and Actin,
expressed as a percentage of the corresponding control condition (mean ± SD of three different
experiments). *p < 0.05 for each condition with respect to the control; one-way ANOVA and Tukey’s post
hoc test.
doi:10.1371/journal.pone.0130726.g006
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neuronal injury, we next investigated the involvement of deacylation and acylation processes
in ROS generation and membrane permeability. To this end, PLA2 isoform-specific inhibitors
and a general inhibitor of lipid acylation (CI-976) were added to the above-mentioned assays.
Dopaminergic neurons were preincubated with 50 μMATK (cPLA2 inhibitor), 10 μMYM
26734 (sPLA2 inhibitor) and 10 μM BEL (iPLA2 inhibitor) and subsequently exposed to metal
incubations. cPLA2 and sPLA2 inhibition did not alter the increase in ROS generation observed
in the presence of Fe, Cu and the combination of both (Fig 7A and 7B). Neither membrane per-
meability (Fig 7C and 7D) nor mitochondrial function (data not shown) were affected by the
inhibition of cPLA2 and sPLA2. However, whereas iPLA2 inhibition was found to strongly in-
crease the generation of ROS in the presence of Fe-induced injury (Fig 8A), membrane perme-
ability and mitochondrial function were slightly affected by iPLA2 inhibition (Fig 8B and 8C).
The inhibition of acyltransferase activities did not alter ROS levels under any of the condi-
tions assayed (data not shown). Nevertheless, lipid peroxide generation and membrane
Fig 7. Role of lipid deacylation mechanismsmediated by sPLA2 and cPLA2 in dopaminergic neurons
exposed to metal-induced injury. (A) Determination of cellular oxidant levels. Cells were treated with Cu2+
(10, 50 μM), Fe2+ overload (1 mM), the combination of both metals or its vehicle for 24 hs in the presence or
absence of cPLA2 inhibitor (ATK 50 μM), and subsequently incubated in the presence of 10 μMDCDCDHF.
Cellular oxidant levels were quantified by spectrofluorimetry. Results are expressed as a percentage of the
control and represent mean ± SD (n = 3). (B) Determination of cellular oxidant levels. Cells were treated with
Cu2+ (10, 50 μM), Fe2+ overload (1 mM), the combination of both metals or its vehicle for 24 hs in the
presence or absence of sPLA2 inhibitor (Ym 26734 10 μM), and subsequently incubated in the presence of
10 μMDCDCDHF. Cellular oxidant levels were quantified by spectrofluorimetry. Results are expressed as a
percentage of the control and represent mean ± SD (n = 3). (C) LDH leakage assay was assessed in cells
after their exposure to Cu2+ (10, 50 μM), Fe2+ overload (1 mM), the combination of both metals or its vehicle
for 24 h in the presence or absence of cPLA2 inhibitor (ATK 50 μM) Results are expressed as a percentage of
the control and represent mean ± SD (n = 3). (D) LDH leakage assay was assessed in cells after their
exposure to Cu2+ (10, 50 μM), Fe2+ overload (1 mM), the combination of both metals or its vehicle for 24 h in
the presence or absence of sPLA2 inhibitor (Ym 26734 10 μM). Results are expressed as a percentage of the
control and represent mean ± SD (n = 3). *Significantly different compared to the respective control group
(p<0.05, one-way ANOVA test followed by Tukey post hoc test)
doi:10.1371/journal.pone.0130726.g007
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Fig 8. Role of lipid deacylation mechanismsmediated by iPLA2 in dopaminergic neurons exposed to
metal-induced injury. (A) Determination of cellular oxidant levels. Cells were treated with Cu2+ (10, 50 μM),
Fe2+ overload (1 mM), the combination of both metals or its vehicle for 24 hs in the presence or absence of
iPLA2 inhibitor (10 μMBEL) and subsequently incubated in the presence of 10 μMDCDCDHF as described
in “Materials and Methods”. Cellular oxidant levels were quantified by spectrofluorimetry. Results are
expressed as a percentage of the control and represent mean ± SD (n = 3). (B) LDH leakage assay was
assessed in cells treated as described in A. Results are expressed as a percentage of the control and
represent mean ± SD (n = 3–4). (C) MTT reduction assay. Cells were treated as described in A and cell
viability was assessed as described in “Materials and Methods”. Results are expressed as a percentage of
the control and represent mean ± SD (n = 3). *Significantly different compared to the respective control group
(p<0.05, one-way ANOVA test followed by Tukey post hoc test). #Significantly different compared to the
respective control group (in the presence of iPLA2 inhibitor, 10 μMBEL)
doi:10.1371/journal.pone.0130726.g008
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Fig 9. Role of lipid acylationmechanisms in dopaminergic neurons exposed to metal-induced injury.
(A) Determination of cellular oxidant levels. Cells were treated with Cu2+ (50 μM), Fe2+ overload (1 mM), the
combination of both metals or its vehicle for 24 hs in the presence or absence of the acylation inhibitor
(7.5 μMCI-976) and subsequently incubated in the presence of 10 μMDCDCDHF as described in “Materials
and Methods”. Cellular oxidant levels were quantified by spectrofluorimetry. Results are expressed as a
percentage of the control and represent mean ± SD (n = 3). (B) LDH leakage assay was assessed in cells
treated as described in A. Results are expressed as a percentage of the control and represent mean ± SD
(n = 3–4). (C) MTT reduction assay. Cells were treated as described in A and cell viability was assessed as
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permeability were observed to be increased by metal-induced neuronal injury in the presence
of CI-976 with respect to controls (Fig 9A and 9B). This was in accordance with a significant
loss of mitochondrial function (Fig 9C).
Discussion
The mechanisms that operate during dopaminergic neuron injury are a major concern for un-
derstanding the ethiopathogenesis of PD. Excessive iron content and the resulting oxidative
stress in the substancia nigra of PD patients are considered triggering factors in this pathology
[2,29,30]. A less clear issue is the state of Cu metabolism [1] although recent findings have
demonstrated that α-syn pathology enhances vulnerability to cell death if Cu-dependent pro-
tective mechanisms are impaired [9]. In this respect, an unexplored field is how lipid acylation/
deacylation cycles operate during dopaminergic neuron degeneration and death. Therefore, for
piecing together the above-mentioned events, lipid acylation mechanisms and their role in oxi-
dative dopaminergic injury triggered by Fe-overload were studied.
Fe-exposed N27 neurons were observed to display increased levels of lipid peroxides and
ROS and also augmented membrane permeability. As a result, Fe-overloaded neurons exhib-
ited slightly diminished mitochondrial viability. Our results as well as previous evidence center-
ing on the role of Fe in dopaminergic degeneration support the viability of the experimental
model used in the present study [10,31]. In line with this, advances in non-dopaminergic treat-
ments for PD are focused in the use of Fe chelators as therapeutic strategy [32]. The condition
of Cu supplementation induced no increase in oxidative stress markers although at the highest
Cu concentration tested, a reduced mitochondrial function was observed. These findings sug-
gest that Fe-overload triggers dopaminergic neuron injury by oxidative stress whereas Cu-me-
diated dopaminergic neurotoxicity does not involve oxidative injury, at least at the
concentrations assayed in the present study.
Neuronal phospholipid acylation and deacylation mechanisms are crucial for the mainte-
nance of axonal and synaptic integrity [33]. Phospholipid membrane deacylation is catalyzed
by different isoforms of PLA2 that generate AA, docosahexaenoic acid and lysophospholipids.
All these bioactive lipids have a variety of physiological effects and also behave as substrates for
the synthesis of other potent lipid mediators, such as eicosanoids, and the lipid peroxides,
4-hydroxynonenal and malondialdehyde. Rapid clearance of peroxidized lipids is a necessary
mechanism for preserving plasma membrane integrity during oxidative stress processes [34–
36]. Our results show a different lipid acylation profile during metal-induced injury. The in-
crease of OA acylation in PS, PI and PE and the decrease of AA incorporation into PS demon-
strate that dopaminergic neurons respond to Fe-induced oxidative injury by switching PL fatty
acid composition to a more saturated profile. The increased preference of OA as an acyl donor
for PL acylation could be indicative of the fact that dopaminergic neurons decreased PUFA lev-
els in their membranes in order to be less prone to peroxidation. Our results agree with previ-
ous findings according to which lipids containing arachidonate are more susceptible to
oxidative degradation [37,38]. These findings are, in turn, in agreement with the membrane
pacemaker hypothesis on ageing, which proposes that animals whose cellular membranes con-
tain high amounts of PUFA have shorter life spans because of their susceptibility to oxidative
stress [39]. In Cu-exposed membranes, PL acylation was opposite to the profile observed in Fe-
exposed neurons as it increased the incorporation of AA into PS –whereas it decreased OA
described in “Materials and Methods”. Results are expressed as a percentage of the control and represent
mean ± SD (n = 3). *Significantly different compared to the respective control group (p<0.05, one-way
ANOVA test followed by Tukey post hoc test)
doi:10.1371/journal.pone.0130726.g009
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labeling in PE. The absence of lipid peroxides in Cu-exposed neurons justify the incorporation
of AA into PS, one of the main reservoirs for this FA in the brain [40].
Differential roles for specific-PLA2 isoforms have been described in several neurodegenera-
tion processes. It has, in fact, been shown that recessively-inherited deficiency in the catalytic
domain of iPLA2 causes neuroaxonal dystrophy [41]. A role for cPLA2 has particularly been ob-
served to be involved in the generation of ROS through AA release in cerebral ischemia events
and iron-induced retinal degeneration [42]. In addition, PL fatty acid composition and PLA2 ac-
tivity have been shown to be related with the progression of AD [43]. In our study, oxidative in-
jury markers, such as ROS content, lipid peroxide levels and membrane permeability, showed to
be increased by the inhibition of iPLA2 (BEL). Furthermore, whereas PLA2s was found to deacy-
late PL in sn-2 position, AT activities were found to be necessary to reacilate this position as
well as to maintain normal phospholipid composition [13]. Previous research also demonstrated
that the loss of lysophosphatidylcholine acyltranferase that renders increased levels of lysopho-
sphatodylcholine generates membrane disruption and Ca2+ influx [44]. Loss of lysophosphati-
dylcholine acyltransferase 1 was found to induce photoreceptor degeneration in rd11 mice [45].
The inhibition of PL acylation processes by CI-976 was observed to yield the same effect as that
of BEL on Fe-exposed neurons. These observations highlight the crucial role of lipid acylation/
deacylation processes in the response of dopaminergic neurons to oxidative injury.
The most striking finding of the present study seems to be the esterification of AA into TAG
in Fe-overloaded neurons. The increase in TAG levels and the appearance of LD suggest that
dopaminergic neurons respond to oxidative injury by the storage of peroxidable fatty acids in
the TAG pool, thus avoiding the permanence of PUFA in PL fraction. The decreased expression
of FAS also strengthens the hypothesis that under oxidative stress conditions dopaminergic neu-
rons avoid the generation of new synthetized FA and exacerbate the mechanisms for preserving
their FA from peroxidation. This strategy seemed to be successful on account of the fact that Fe-
overloaded neurons were found to avoid a significant death. Regarding PD experimental mod-
els, rotenone, a mitochondrial toxicant, also triggers TAG accumulation in C2C12 cells [46].
Taken together, findings from the present study provide evidence about the participation of
lipid acylation mechanisms against Fe-induced oxidative stress in N27 cells and postulate that
dopaminergic neurons strategically preserve AA pool in TAG in response to oxidative injury
(Fig 10). Further studies in this direction will provide new knowledge on PD pathogenesis
which could pave the way towards new preventive or therapeutic strategies.
Fig 10. Lipid acylation mechanisms in Fe-induced dopaminergic neurons injury. Fe-induced oxidative
stress triggers the accumulation of AA into TAG and the increase of OA-containing PL. The inhibition of lipid
acylation/deacylation mechanisms exacerbates Fe-induced dopaminergic damage.
doi:10.1371/journal.pone.0130726.g010
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